Pain Assessment in Pediatric Patients with Primary Bone Cancer in a Single Site Cohort
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3299Keywords:
sarcoma, Ewing, osteosarcoma, pain management, death, bone neoplasmsAbstract
Introduction: Pain is the main symptom described in cancer patients. Objective: To assess pain classification and management in pediatric patients with primary bone cancer over time: admission, during treatment and follow-up, and to investigate factors associated with pain classification at the last assessment. Method: Retrospective cohort study of osteosarcoma and Ewing's sarcoma cases in individuals <19 years old treated at a single cancer referral site and followed up by a multidisciplinary team. The primary endpoint was pain score at the last assessment. Secondary outcome: evolution of pharmacological treatment. Results: 142 patients were included. The frequency of pain assessment increased during the study period from 53.5% at admission to 68.3% during treatment and 85.9% in follow-up. Of the patients who had pain assessed, 65.8% had pain at admission and 26.2% at the end of the study. There was an increase in the use of strong opioids and antidepressants. In the last evaluation, 56 patients (39.4%) were at the end-of-life and this was not associated with more pain (p=0.68). Meanwhile, those who had more pain used strong opioids (p=0.01) or steroids (p=0.03). Conclusion: Pain management during treatment resulted in increased use of strong opioids and antidepressants with pain reduction, revealing that pain control is possible. In the last assessment, end-of-life patients no longer had pain and patients with pain were the ones who used strong opioids and steroids at the most, showing the difficulty of pain control in some patients.
Downloads
References
Instituto Nacional de Câncer. Estimativa 2023: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2022 [acesso 2023 fev 14]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353(9165):1695-700. doi: https://doi.org/10.1016/S0140-6736(99)01310-0 DOI: https://doi.org/10.1016/S0140-6736(99)01310-0
van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9. doi: https://doi.org/10.1016/j.jpainsymman.2015.12.340 DOI: https://doi.org/10.1016/j.jpainsymman.2015.12.340
Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7(2):CD012592. doi: https://doi.org/10.1002/14651858.CD012592.pub2 DOI: https://doi.org/10.1002/14651858.CD012592.pub2
Mikan F, Wada M, Yamada M, et al. The association between pain and quality of life for patients with cancer in an outpatient clinic, an inpatient oncology ward, and inpatient palliative care units. Am J Hosp Palliat Care. 2016;33(8):782-90. doi: https://doi.org/10.1177/1049909116630266 DOI: https://doi.org/10.1177/1049909116630266
Marec-Bérard P, Delafosse C, Foussat C. Douleurs et tumeurs osseuses malignes de l'enfant et de l'adolescentCancer-related bone pain in children. Arch Pediatr. 2005;12(2):191-8. doi: https://doi.org/10.1016/j.arcped.2004.11.026 DOI: https://doi.org/10.1016/j.arcped.2004.11.026
Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP task force on cancer pain. International Association for the study of pain. Pain. 1999;82(3):263-74. doi: https://doi.org/10.1016/S0304-3959(99)00073-1 DOI: https://doi.org/10.1016/S0304-3959(99)00073-1
Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am. 2000;82(5):667-74. doi: https://doi.org/10.2106/00004623-200005000-00007 DOI: https://doi.org/10.2106/00004623-200005000-00007
Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. In: Jaffe N, Bruland OS, Bielack S, editors. Pediatric and adolescent osteosarcoma. Boston (MA): Springer; 2009. p. 3-13. doi: http://link.springer.com/10.1007/978-1-4419-0284-9_1 DOI: https://doi.org/10.1007/978-1-4419-0284-9_1
Zernikow B, Szybalski K, Hübner-Möhler B, et al. Specialized pediatric palliative care services for children dying from cancer: a repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med. 2019;33(3):381-91. doi: https://doi.org/10.1177/0269216318818022 DOI: https://doi.org/10.1177/0269216318818022
Madden K, Magno Charone M, Mills S, et al. Systematic symptom reporting by pediatric palliative care patients with cancer: a preliminary report. J Palliat Med. 2019;22(8):894-901. doi: https://doi.org/10.1089/jpm.2018.0545 DOI: https://doi.org/10.1089/jpm.2018.0545
Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985-91. doi: https://doi.org/10.1093/annonc/mdn419 DOI: https://doi.org/10.1093/annonc/mdn419
Maltoni M. Opioids, pain, and fear. Ann Oncol. 2008;19(1):5-7. doi: https://doi.org/10.1093/annonc/mdm555 DOI: https://doi.org/10.1093/annonc/mdm555
Senerchia AA, Macedo CR, Ferman S, et al. Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: a report from the Latin American Group of Osteosarcoma Treatment. Cancer. 2017;123(6):1003-10. doi: https://doi.org/10.1002/cncr.30411 DOI: https://doi.org/10.1002/cncr.30411
Becker RG, Gregianin LJ, Galia CR, et al. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. BMC Cancer. 2017;17(1):420. doi: https://doi.org/10.1186/s12885-017-3391-5 DOI: https://doi.org/10.1186/s12885-017-3391-5
Snaman JM, Baker JN, Ehrentraut JH, et al. Pediatric oncology: managing pain at the end of life. Pediatr Drugs. 2016;18(3):161-80. doi: https://doi.org/10.1007/s40272-016-0168-2 DOI: https://doi.org/10.1007/s40272-016-0168-2
Chi NC, Demiris G. Family caregivers’ pain management in end-of-life care: a systematic review. Am J Hosp Palliat Care. 2017;34(5):470-85. doi: https://doi.org/10.1177/1049909116637359 DOI: https://doi.org/10.1177/1049909116637359
Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14(1):9-17.
Anghelescu DL, Snaman JM, Trujillo L, et al. Patient-controlled analgesia at the end of life at a pediatric oncology institution. Pediatr Blood Cancer. 2015;62(7):1237-44. doi: https://doi.org/10.1002/pbc.25493 DOI: https://doi.org/10.1002/pbc.25493
Reinfjell T, Zeltzer L. A systematic review of self-reported pain in childhood cancer survivors. Acta Paediatr. 2020;109(1):56-70. doi: https://doi.org/10.1111/apa.14977 DOI: https://doi.org/10.1111/apa.14977
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Geneva: World Health Organization; 2012.
Friedrichsdorf SJ. Pain management in children with advanced cancer and during end-of-life care. Pediatr Hematol Oncol. 2010;27(4):257-61. doi: https://doi.org/10.3109/08880011003663416 DOI: https://doi.org/10.3109/08880011003663416
Fernández Urtubia B, Trevigno Bravo A, Rodríguez Zamora N, et al. Uso de opiáceos en niños con cáncer avanzado en cuidados paliativos. Rev Chil Pediatr. 2016;87(2):96-101. doi: https://doi.org/10.1016/j.rchipe.2015.10.006 DOI: https://doi.org/10.1016/j.rchipe.2015.10.006
Edmonds KP, Saunders IM, Willeford A, et al. Emerging challenges to the safe and effective use of methadone for cancer-related pain in paediatric and adult patient populations. Drugs. 2020;80(2):115-30. doi: https://doi.org/10.1007/s40265-019-01234-6 DOI: https://doi.org/10.1007/s40265-019-01234-6
Anghelescu DL, Tesney JM. Neuropathic pain in pediatric oncology: a clinical decision algorithm. Pediatr Drugs. 2019;21(2):59-70. doi: https://doi.org/10.1007/s40272-018-00324-4 DOI: https://doi.org/10.1007/s40272-018-00324-4
Brown ML, Rojas E, Gouda S. A mind-body approach to pediatric pain management. Children (Basel). 2017;4(6):50. doi: https://doi.org/10.3390/children4060050 DOI: https://doi.org/10.3390/children4060050
Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342(5):326-33. doi: https://doi.org/10.1056/NEJM200002033420506 DOI: https://doi.org/10.1056/NEJM200002033420506
Lykke C, Ekholm O, Olsen M, et al. Paediatric end-of-life care - symptoms and problems: parent assessment. BMJ Support Palliat Care. 2021;bmjspcare-2021-002891. doi: https://doi.org/10.1136/bmjspcare-2021-002891 DOI: https://doi.org/10.1136/bmjspcare-2021-002891
Pritchard M, Burghen EA, Gattuso JS, et al. Factors that distinguish symptoms of most concern to parents from other symptoms of dying children. J Pain Symptom Manage. 2010;39(4):627-36. doi: https://doi.org/10.1016/j.jpainsymman.2009.08.012 DOI: https://doi.org/10.1016/j.jpainsymman.2009.08.012
Leeuw TG, Mangiarini L, Lundin R, et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20(1):49. doi: https://doi.org/10.1186/s13063-018-3169-3 DOI: https://doi.org/10.1186/s13063-019-3519-9
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
